Journal of Medicinal Chemistry · 2011 · 48 citations · 11 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryLead OptimizationStructural BiologyFragment-based Drug DesignFragment-based Lead DiscoveryFragment-based OptimizationLead DiscoveryLigand BindingMolecular DockingFragment-based DiscoveryFragment-based Lead DesignFragment-based Lead OptimizationIndole DerivativesMatrix Metalloproteinase InhibitorsMatrix Metalloproteinase TargetsStructure-based Lead DiscoveryStructure-guided Lead Discovery
Matrix metalloproteases (MMPs) play an important role in cartilage homeostasis under both normal and inflamed disease states and, thus, have become attractive targets for the treatment of arthritic diseases. Herein, we describe the identification of a potent, selective MMP-13 inhibitor, developed using fragment-based structure-guided lead identification and optimization techniques. Virtual screening methods identified a novel, indole-based MMP-13 inhibitor that bound into the S1' pocket of the protein exhibiting a novel interaction pattern hitherto not observed in MMP-13 inhibitors. X-ray crystallographic structures were used to guide the elaboration of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over nine other MMP isoforms tested.
11
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Suzanne B. Shuker, Philip J. Hajduk, Robert Meadows et al. · Science · 1996 · 2K citations
Structural Basis for the Highly Selective Inhibition of MMP-13
Christian K. Engel, Bernard Pirard, Sandra Schimanski et al. · Chemistry & Biology · 2005 · 223 citations · Full text
Identification of potent and selective MMP-13 inhibitors
Junjun Wu, Thomas S. Rush, Rajeev Hotchandani et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 70 citations · Full text